Obesity between 13 to 16 Years Students Visiting General Hospital "Cross-Sectional Study"
The medical definition of "obesity" is an excess of fat, while the definition of "overweight" is an excess of physical weight. In the industrialized world, student obesity has become a major public health issue. The growing epidemic of obesity in the world's poorest countries is even more cause for alarm. The worldwide epidemic of student obesity has received a lot of attention. Students, adolescents and adults who are overweight are at increased risk for a variety of health issues. A major public health concern has developed with the alarming increase in childhood obesity rates. Children and adolescents who are overweight are at increased risk for developing cardiometabolic disorders. Risks that might arise. Obesity in adolescents is associated with greater mortality and a higher likelihood of continuing to acquire weight as an adult. Because of the far-reaching effects of obesity, effective treatments are urgently required. The recommended therapy is a behavioral shift. The great majority of people who try to reduce weight and make changes to their lifestyle fail in the long run, as shown by real-world data. If a person's weight gain and associated health problems do not decrease after following a structured program to make lifestyle changes, pharmaceutical intervention may be warranted. However, the European Medicines Agency (EMA) did not approve any pharmacotherapeutic medicines for childhood obesity. In April of 2021, the European Medicines Agency authorized the use of liraglutide, a Glucagon-Like Peptide (GLP)-1 analog, for the treatment of obesity in children and adolescents aged 12 to 17. The effectiveness and safety of Liraglutide were established in a randomized, double-blind study with 251 people.Compared to the placebo group, those taking liraglutide were more likely to have dropped at least 5% of their body weight after 56 weeks (43.3% vs. 18.7%). The digestive system was implicated in the vast majority of reported adverse events with liraglutide. Bariatric surgery is a potential treatment option for those who are severely obese because to the long-term benefits of weight loss and lowered cardiometabolic risk factors. The long-term safety and efficacy of, however, is poorly understood. Some of the hazards associated with bariatric surgery include the need for further abdominal procedures and nutritional deficiencies. Success rates may improve as a result of integrating novel pharmacological therapy with behavioral modifications. Obesity in adolescents, cardiometabolic risk factors and the use of GLP1 receptor agonists as a therapeutic intervention. Results: The total sample studied in this research was (450) of the students. The age group was taken from 13to16 years. Conclusions: The prevalence of overweight and obesity among students attending was 72 cases (16%) and 30 cases (6.7%), respectively. Aim: This study aim to assess the health of students and detection some of the risk factors and problemes of obesity for better students welfare.